BioWorld

Nov. 24, 2014

View Archived Issues

Phosphorous down, iron up in new treatment options for dialysis patients

Nephrologists are set to get one and possibly two new drugs in their medicine bag to treat chronic kidney disease (CKD) patients on dialysis. Read More

Word on the street

Read More

Week in review

Read More

Week in Washington

Read More

Top 10 bio/pharma deals in 2014

Read More

Collaborations between biotech and pharmaceutical companies: October 1 - November 20, 2014

Read More

Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: October 1 - November 20, 2014

Read More

Biotech-big pharma collaborations: Modified agreements: October 1 - November 20, 2014

Read More

Biotech-big pharma collaborations: terminated agreements: October 1 - November 20, 2014

Read More

Biotechnology collaborations between pharmaceutical and miscellaneous companies: October 1 - November 20, 2014

Read More

Money raised by biotech in 2014 vs. 2013

Read More

Money raised by biotech Jan. 1 - Nov. 20, 2014

Read More

The week's biggest gainers and losers

Read More

BioWorld stock report for public biotechnology companies

Read More